EnerVenue | $300,000,000 | (Apr 3, 2026)
Acurion, Inc. | $4,300,000 | (Apr 3, 2026)
Gander Robotics | $1,100,000 | (Apr 3, 2026)
Zumutor Biologics
United States
- Cambridge, MA
- 09/12/2021
- Series A
- $6,200,000
At Zumutor, we are on a mission to develop novel novel immuno onco-therapeutics that drive transformational improvements in cancer treatment through NK cell engagement. We leverage our proven proprietary antibody discovery- INABLR™ for fast track Antibody discovery and development.
Our team works in collaboration with a world class Scientific Advisory Board with expertise in immuno-oncology and clinical development. Our lead asset (ZM008) is a first-in-class antibody that targets certain receptors that blocks NK cell inhibitory signal and enables NK cell activation to generate a potent immune response. Development is on track for an IND filing by Q2 2022 and Phase 1 clinical trial thereafter.
We are headquartered in CIC Cambridge Campus, MA and R&D is carried out at ISO certified lab in Bangalore, India
- Industry Biotechnology Research
- Website https://www.zumutor.com/about/
- LinkedIn https://www.linkedin.com/company/zumutor/about/
Related People
Kavitha Iyer RodriguesFounder
India -
Bengaluru, Karnataka,
Expertise in core Biologics development, Management and Ops.
End to end experience with a previous start-up (Inbiopro), successfully exited the start-up to a listed Bangalore based pharma company through a strategic buy out.
Mentor/ Advisor to multiple entrepreneurs/ start-ups.
Technical experience ranging from :
Enzymes, Method Development combined with Process and Product development knowledge in Biologics. Strategic planning, management, ops, knowledge transition and successful product delivery- Biosimilars and NBEs.
Recent success with platform technologies for Novels combined with a patent portfolio.
Novel Antibody development.
Numos | $4,250,000 | (Apr 3, 2026)
Alien | $7,100,000 | (Apr 3, 2026)
Monarch Quantum | $55,000,000 | (Apr 3, 2026)
Sona(UK) | $45,000,000 | (Apr 2, 2026)
Linx Security | $50,000,000 | (Apr 2, 2026)
Earlyasset | $2,000,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)
Whirl AI | $8,900,000 | (Apr 2, 2026)